Your session is about to expire
← Back to Search
E-cigarettes for Smoking Reduction in Adults with Asthma (SWAP Trial)
SWAP Trial Summary
This trial will test whether adults with asthma who smoke cigarettes will substitute ENDS for cigarettes, reduce dependence, and improve lung function.
SWAP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSWAP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 4 trial • 127 Patients • NCT01400243SWAP Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the cut-off age for enrolment into this clinical trial under 25 years?
"The trial is currently taking applicants who are younger than 65 and at least of legal age."
How can I become a participant in this research project?
"The requirements for enrollment in this trial are asthma and an age between 21-65. The number of patients necessary to complete the research is 30."
What is the sample size of individuals receiving treatment in this clinical experiment?
"Affirmative. Clinicaltrials.gov attests that this medical study, initially posted in May 1st 2022, is presently searching for 30 participants from one centre. The data was last updated on July 18th of the same year."
Are there currently any open opportunities for patient involvement in this experiment?
"The details on clinicaltrials.gov demonstrate that this trial is still in search of participants, with the posting first appearing on May 1st 2022 and most recently being updated July 18th 2022."
Share this study with friends
Copy Link
Messenger